地塞米松改善临床前细菌性附睾炎小鼠模型的治疗结局
研究在UPEC诱导的细菌性附睾炎小鼠模型中,比较左氧氟沙星单用、地塞米松单用及两者联用的效果。联用未进一步损害组织完整性,并减轻适应性免疫反应和远期组织损伤;但动物因输精管结扎未能进行生育力评估。
要点
- 地塞米松联用抗菌治疗未进一步损害附睾组织完整性。
- 联用组附睾管连续性保留、允许精子通过,并降低全身IgG、IgM及CD3水平。
- 左氧氟沙星单用或联用组局部细胞因子转录水平较未治疗感染组显著降低。
核心结论
- 地塞米松联合抗菌治疗通过抑制宿主适应性免疫反应,有效减少细菌性附睾炎小鼠远期附睾组织损伤。
研究设计与样本
- 采用尿路致病性大肠埃希菌(UPEC)诱导成年雄性C57BL/6J小鼠细菌性附睾炎模型。
- 感染后第3天起,每日给予左氧氟沙星20 mg/kg(共12只)、地塞米松0.5 mg/kg(共9只)或两者联用(共11只),连续7天。
- 对照组为UPEC感染后不接受干预治疗(共11只)。
- 每组半数动物分别于感染后10天或31天处死。
主要发现
- 联用组在感染后10天和31天均观察到免疫反应明显减弱、组织反应/损伤减少,附睾管连续性保留、允许精子通过。
- 未治疗或单用抗生素组出现附睾管损伤和管腔狭窄,并伴附睾尾精子缺失。
- 与UPEC感染未治疗组相比,左氧氟沙星单用组局部细胞因子转录水平显著降低(P < 0.01),联用组亦显著降低(P < 0.05)。
- 联用组在感染后10天和31天全身IgG、IgM水平及泛T细胞标志物CD3均降低。
- 对附睾炎患者临床数据与血清IgG、IgM水平的相关性分析已进行(原文未报告具体结果)。
局限性
- 因模型特异性输精管结扎,无法在实验动物中开展评估联合治疗生育保护作用的繁殖研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can dexamethasone improve infertility-related cauda epididymidal tissue damage caused by bacterial epididymitis? SUMMARY ANSWER: Dexamethasone in addition to anti-microbial treatment effectively reduces long-term deleterious epididymal tissue damage by dampening the host's adaptive immune response. WHAT IS KNOWN ALREADY: Despite effective anti-microbial treatment, ~40% of patients with epididymitis experience subsequent sub- or infertility. An epididymitis mouse model has shown that the host immune response is mainly responsible for the magnitude of epididymal tissue damage that is fundamentally causative of the subsequent fertility issues. STUDY DESIGN, SIZE, DURATION: Bacterial epididymitis was induced in male mice by using uropathogenic Escherichia coli (UPEC). From Day 3 after infection onwards, mice were treated with daily doses of levofloxacin (20 mg/kg, total n = 12 mice), dexamethasone (0.5 mg/kg, total n = 9) or both in combination (total n = 11) for seven consecutive days. Control animals were left untreated, i.e. given no interventional treatment following UPEC infection (total n = 11). Half of the animals from each group were killed either at 10 or 31 days post-infection. PARTICIPANTS/MATERIALS, SETTING, METHODS: A mouse model of induced bacterial epididymitis was applied to adult male C57BL/6J mice. At the respective endpoints (10 or 31 days post-infection), epididymides were collected. Effectiveness of antibiotic treatment was assessed by plating of epididymal homogenates onto lysogeny broth agar plates. Overall tissue morphology and the degree and nature of tissue damage were assessed histologically. Quantitative RT-PCR was used to assess local cytokine transcript levels. Blood was drawn and serum analysed for systemic IgG and IgM levels by ELISA. In addition, correlation analyses of clinical data and serum-analyses of IgG and IgM levels in patients with epididymitis were performed. MAIN RESULTS AND THE ROLE OF CHANCE: The addition of dexamethasone to the standard anti-microbial treatment did not further worsen epididymal tissue integrity. In fact, an obviously dampened immune response and reduced tissue reaction/damage was observed at both 10 and 31 days post-infection following combined treatment. More specifically, epididymal duct continuity was preserved, enabling sperm transit. In contrast, in untreated or antibiotic-treated animals, damage of the epididymal duct and duct constrictions were observed, associated with a lack of cauda spermatozoa. In line with the bacteriostatic/bactericidal effect of levofloxacin (alone as well as in combination), local cytokine transcript levels were significantly and similarly reduced in animals treated with levofloxacin alone (P < 0.01) or in combination with dexamethasone (P < 0.05) compared to UPEC-infected untreated animals. Interestingly, the addition of dexamethasone to the anti-microbial treatment induced a unique dampening effect on adaptive immunity, since systemic IgG and IgM levels as well as the pan-T cell marker CD3 were reduced at both 10 and 31 days post-infection. LIMITATIONS, REASONS FOR CAUTION: Breeding studies to address the fertility-protecting effect of the combined treatment were not possible in the experimental animals because the vas deferens was ligated (model specific). WIDER IMPLICATIONS OF THE FINDINGS: Whereas innate immunity is necessary and involved in acute bacterial clearance, adaptive immunity seems to be responsible for long-term, subclinical immunological activities that may negatively affect the pathogenesis of bacterial epididymitis even after effective bacterial eradication. These effects can be reduced in mice by the additional treatment with dexamethasone. This immunological characteristic of bacterial epididymitis shows similarities to the Jarisch-Herxheimer reaction known from other types of bacterial infection. STUDY FUNDING/COMPETING INTEREST(S): The study was supported by grants from the Deutsche Forschungsgemeinschaft, Monash University and the Medical Faculty of Justus-Liebig University to the International Research Training Group on 'Molecular pathogenesis of male reproductive disorders' (GRK 1871). R.W., K.L.L. and M.P.H. were supported by grants from the National Health and Medical Research Council of Australia (ID1079646, ID1081987, ID1020269 and ID1063843) and by the Victorian Government's Operational Infrastructure Support Program. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: No clinical trial involved.
引用
- Klein B, Pant S, Bhushan S, et al. Dexamethasone improves therapeutic outcomes in a preclinical bacterial epididymitis mouse model. Hum Reprod. 2019. PMID: 31211847. doi:10.1093/humrep/dez073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。